Industries > Pharma > Global Pharma Contract Sales Market 2018-2028

Global Pharma Contract Sales Market 2018-2028

Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services

PUBLISHED: 31 January 2018
PAGES: 242
PRODUCT CODE: PHA0281

Clear
WOOCS 2.2.1
SKU: PHA0281 Categories: , ,

The global pharma contract sales market is expected to grow at a CAGR of 9.6% in the first half of the forecast period. The market is expected to grow at a CAGR of 7.9% from 2017-2028. The market is estimated at $5.48bn in 2017 and $9.48bn in 2023.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector. 

In this brand new 242-page report you will receive 90 tables and 65 figures– all unavailable elsewhere. 

The 242-page report provides clear detailed insight into the global pharma contract sales market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Pharma Contract Sales Market forecasts from 2018-2028

• Along with revenue prediction for the overall world market for pharma contract sales market, our investigation shows forecasts to 2028 for the following submarkets:
– Contract detailing (personal promotion/field sales)
– Contract non-personal promotion, with further sub-forecasting for teledetailing, eDetailing and others
– Medical education services
– Sample management services

This report also breaks down the revenue forecast for pharma contract sales market by therapeutic segments:
– Cardiovascular disease
– Metabolic disorders
– Cancer treatment
– Other 

• This report provides individual revenue forecasts to 2028 for these regional and national markets:
– USA
– Japan
– Germany, UK, France, Italy and Spain (EU5 countries)
– China, India, Brazil and Russia (BRIC group)

Global Pharma Contract Sales Market 2018-2028

• Our study discusses the SWOT and STEP factors of the global pharma contract sales market

• Our study discusses issues affecting the pharma contract sales industry and market from 2017:
– Outsourced and in-house sales reps – trends and emerging sales models, including multiple channels (multichannel marketing to medical professionals)
Services CSOs offer and benefits to drug companies outsourcing medical sales
– Maturing brands and product launches, including flexibility in field sales teams
Legislation and new market access requirements for pharma sales representatives 
– Changes to online marketing and potential for IT technologies Risk-sharing agreements
Key account management (KAM) and medical science liaison (MSL)

• This report discusses the leading companies in pharma contract sales

Visiongain’s study is intended for anyone requiring commercial analyses for the global pharma contract sales market. You find data, trends and predictions. 

Buy our report today Global Pharma Contract Sales Market 2018-2028: Contract Detailing, Contract Non-Personal Promotion, Medical Education Services, Sample Management Services, Teledetailing Services, Edetailing Services.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Global Pharma Contract Sales Market 2018-2028


Latest Pharma news

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

READ

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Categories

Category